ARONETTE AZU: Open Payments
NPI 1811463672 · COPPELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,761 in 106 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,761
Food & beverage: $2,600Education: $161
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $598 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $472 |
| ABBVIE INC. | 19 | $443 |
| Madrigal Pharmaceuticals | 2 | $164 |
| Regeneron Healthcare Solutions, Inc. | 6 | $158 |
| Ipsen Biopharmaceuticals, Inc | 5 | $157 |
| Ardelyx, Inc. | 6 | $109 |
| Aimmune Therapeutics, Inc. | 5 | $108 |
| QOL Medical, LLC | 3 | $105 |
| GENZYME CORPORATION | 5 | $100 |
Products named: TREMFYA, ENTYVIO, RINVOQ, DUPIXENT, REZDIFFRA, IQIRVO, IBSRELA, Sucraid.
Industry payments across TX — which companies pay providers there.
